
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
The Long Run with Luke Timmerman
Is Manufacturing a Top Priority?
As we've moved to more complex type of medicines, it started with bilogics. Manufacturing is becoming really the rate limiting step. And many companies are not able to get past the regulatory scrutiny just because they don't have witth clinical data.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.